Physician profile
Jane E Mossberg
NPI 1568573053
$2,087.47
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $734 · 2020: $253 · 2021: $361 · 2022: $181 · 2023: $430 · 2024: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $557.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $508.65 | 2019-2023 | Repatha, Otezla |
| Novo Nordisk INC | $421.49 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $325.83 | 2019-2023 | Airsupra |
| Abbvie INC. | $279.02 | 2021-2024 | |
| Pfizer INC. | $268.70 | 2019-2024 | |
| Exact Sciences Corporation | $58.42 | 2023-2024 | Cologuard Collection Kit |
| Allergan, INC. | $47.49 | 2019 | |
| Sanofi-Aventis U.S. LLC | $43.69 | 2020-2021 | |
| Nestle Healthcare Nutrition INC. | $33.79 | 2021 | |
| Xeris Pharmaceuticals, INC. | $17.20 | 2023 | Gvoke Hypopen |
| Abbott Laboratories | $17.12 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $14.84 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.55 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.92 | 2019 | |
| Daiichi Sankyo INC. | $12.60 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Mossberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.